U.S. Department of Health and Human Services (HHS) unveiled a plan to directly negotiate prices for drugs in Medicare parts B and D. It would allow those prices also being available to private insurance plans and any employers who want to participate. The plan lays out a series of administration actions the department could take to fulfill three principles: Making drugs more affordable, improving competition within the industry, and encouraging innovation. Read the article here for more details.
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org